Post Marketing Information DHCPL 18/03/2024 Zyrtec-D - Risks of posterior reversible encephalopathy syndrome and reversible cerebral vasoconstriction syndrome associated with the use of pseudoephedrine
ORAL Select a brand starting with the letter: A AERIUS D-12 MODIFIED RELEASE TABLETS 2.5MG/120MG [SIN13772P]